Bevacizumab: Difference between revisions
From IDWiki
Content deleted Content added
Created page with "* Recombinant humanized IgG1 anti-VEGF monoclonal antibody * Indications include advanced colorectal cancer, non-small cell lung cancer, breast cancer, and renal cancer ** May..." |
(No difference)
|
Latest revision as of 11:26, 17 March 2022
- Recombinant humanized IgG1 anti-VEGF monoclonal antibody
- Indications include advanced colorectal cancer, non-small cell lung cancer, breast cancer, and renal cancer
- May be used as an intravitreal injection for macular degeneration
- Black-box warning for intestinal perforation
- Infectious complications include intra-abdominal infection, febrile neutropenia, pneumonitis, and possibly also Bacteroides fragilis liver abscess and Fusarium-associated nasal septal perforation
